Retail sale of pharmaceutical products
PHARMAX AS
Operating profit
NOK −10,000
Equity
NOK 650,000
Incorporated
2020
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.00
Equity ratio
49.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -0.8% | |
| Likviditet | ||
| Current ratio | 1.00 | |
| Working capital | 384 | |
| Soliditet | ||
| Equity ratio (%%) | 49.6% | |
| Debt-to-equity ratio | 1.02 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.